Valtrex herpes transmission indication
Executive Summary
GlaxoSmithKline's Valtrex (valacyclovir) clears FDA for reduction of the risk of heterosexual transmission of genital herpes when used as a suppressive therapy in combination with safer sex practices. The approval follows the recommendations of the Antiviral Drugs Advisory Committee during a May 14 meeting (1"The Pink Sheet" May 19, 2003, p. 14)...